Literature DB >> 23657943

A simple system to predict perihilar cholangiocarcinoma resectability.

Karim Boudjema1, Laurent Sulpice, Sylvain Garnier, Jean-François Bretagne, Yves Gandon, Tanguy Rohou.   

Abstract

BACKGROUND: The aim of this study was to retrospectively validate a new system to predict perihilar cholangiocarcinoma (PHC) resectability. We hypothesized that when the left lateral section (segments II-III) duct confluence (LLC) is free, the left lateral section might be preserved for curative resection. When the LLC is invaded, vascular invasion is frequent and radical resection might often be impossible without complex vascular reconstruction.
METHOD: Radiological files of patients operated for PHC at our institution were reviewed and PHC was classified depending on whether LLC was invaded (type X) or free (type Y). Peroperative findings and follow-up were then matched with our XY classification.
RESULTS: Thirty-seven patients were included, 28 (78 %) type Y and nine (22 %) type X PHCs. Hepatic artery (HA) invasion was present in 14 % of type Y and 100 % of type X PHCs (P < 0.001). Left HA was never involved in type Y and always involved in type X. Portal vein invasion was present in 25 and 78 % of type Y and type X PHC, respectively (P = 0.014). Complete resection rates without HA in type Y and X patients were 89 % (84 % R0 and 16 % R1) and 33 % (37.5 % R0 and 12.5 % R1), respectively (P = 0.01). Sensitivity, specificity, and precision of the XY classification to predict resectability were 84, 67, and 84 %, respectively.
CONCLUSION: XY classification for PHCs suggests that in type Y (free LLC), the tumor is most often resectable, while in type X (LLC involved), the tumor is only resectable using complex vascular reconstructions.

Entities:  

Mesh:

Year:  2013        PMID: 23657943     DOI: 10.1007/s11605-013-2215-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Klatskin tumors and the accuracy of the Bismuth-Corlette classification.

Authors:  Andreas Paul; Gernot M Kaiser; Ernesto P Molmenti; Tobias Schroeder; Spiridon Vernadakis; Arzu Oezcelik; Hideo A Baba; Vito R Cicinnati; Georgios C Sotiropoulos
Journal:  Am Surg       Date:  2011-12       Impact factor: 0.688

2.  Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.

Authors:  Yuji Shingu; Tomoki Ebata; Hideki Nishio; Tsuyoshi Igami; Yoshie Shimoyama; Masato Nagino
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

3.  Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.

Authors:  Seiji Natsume; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yoshie Shimoyama; Masato Nagino
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

4.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

5.  The concept of perihilar cholangiocarcinoma is valid.

Authors:  T Ebata; J Kamiya; H Nishio; T Nagasaka; Y Nimura; M Nagino
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

6.  Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.

Authors:  Hiroaki Shimizu; Fumio Kimura; Hiroyuki Yoshidome; Masayuki Ohtsuka; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Masaru Miyazaki
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

Review 8.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

9.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

10.  Study of the intrahepatic surgical margin of hilar bile duct carcinoma.

Authors:  Yasunaga Okazaki; Tadashi Horimi; Masahito Kotaka; Sojiro Morita; Motohiro Takasaki
Journal:  Hepatogastroenterology       Date:  2002 May-Jun
View more
  5 in total

Review 1.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

2.  Clinical significance of anatomical variant of the left hepatic artery for perihilar cholangiocarcinoma applied to right-sided hepatectomy.

Authors:  Hiroaki Shimizu; Isamu Hosokawa; Masayuki Ohtsuka; Atsushi Kato; Hideyuki Yoshitomi; Masaru Miyazaki
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

3.  Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?

Authors:  Heithem Jeddou; Stylianos Tzedakis; Francesco Orlando; Antoine Robert; Eric Meneyrol; Damien Bergeat; Fabien Robin; Laurent Sulpice; Karim Boudjema
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

Review 4.  Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.

Authors:  D Brock Hewitt; Zachary J Brown; Timothy M Pawlik
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 5.  An update on liver surgery for cholangiocarcinoma.

Authors:  Karim Boudjema; Giovanni Battista Levi Sandri; Eveline Boucher; Tanguy Rohou; Michel Rayar; Laurent Sulpice
Journal:  Updates Surg       Date:  2013-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.